Research Synthesis: Intermittent Fasting (IF)

Artifact

Living evidence brief from agent-v3-full-paper-live

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reconcile the Directness Map table in What This Synthesis Adds with the Results outcome-class table; either remove the redundant table or annotate that the 'direct' counts are cumulative across the outcome class and match the Results slice.
2. Either transcribe the Khalafi 2025a numeric SMDs into the Immune and Inflammation Results prose (with exact bundle tokens) or clearly mark the immune subsection as containing no transcribed bundle-supported numerics.
3. Audit all 'exact source:' quoted numerics (Couto-Alfonso, Guo, Abdullah, Dai, Lu, etc.) against the bundle excerpts and either remove any that cannot be matched to a bundle quote or add the matching PMID/DOI with the exact bundle token.
4. Recode the direction tags for Li 2026 and He 2026 in the Tensions and Gaps section so that the 'positive vs negative' framing reflects the bundle-supported effect directions, or rewrite the surfaced tensions to match the actual direction codes.
5. Add a brief funnel and exclusion note to Methods to explain the 100% inclusion rate and the upstream non-admission buckets.
6. Provide a one-sentence operational definition of 'non-orthogonal dyad' so the 706-count claim is auditable.

Major issues

• The 'Directness Map' table under What This Synthesis Adds contains an internal contradiction: it lists 8 direct sources for the cardiometabolic outcome class (consistent with the Results table showing 8 direct + 8 indirect + 2 protocol + 23 review = 41 sources), yet the Discussion states 'immune and inflammation (0 direct)' while the Results table shows only 2 indirect + 1 protocol + 2 review for that slice — the cross-section inconsistency should be reconciled or the contradictory table should be removed.
• The Results section's Muscle Function and Immune and Inflammation prose subsections assert 'context-dependent' and 'preliminary' verdicts while the source bundle for Khalafi 2025a directly reports numeric SMDs with CIs (TNF-α SMD -0.31 p=0.009, CRP SMD -0.19 p=0.04, leptin SMD -0.57 p=0.005) — the manuscript should transcribe these bundle-supported numerics into the immune/inflammation subsection or clearly mark them as not transcribed because they fall in a separate biomarker-coded source.
• Several exact numeric claims are presented with full traceable tokens (Obermayer HbA1c -7.3 mmol/mol P=0.012, Tay HbA1c p<0.001, Kibret body weight MD -5.18 kg, Li body weight MD -1.29 kg, He BMI MD -0.41 P=0.0396, Qudah HbA1c pooled -1.85 95% CI -2.86 to -0.84) but other headline numerics (e.g. Couto-Alfonso TRE 16:8 -1.92 kg, Guo combined 6.3 kg 95% CI -8.2 to -4.5 kg) are presented without source-claim verification against the bundle excerpts and should either be removed or traced to the bundle span.
• The 'Tensions and Gaps' section claims 3 surfaced source-pair disagreements and lists Herz 2024 vs He 2026 plus Herz 2024 vs Li 2026 as BMI direction conflicts; however Li 2026 reports a negative effect (IF reduced body weight vs CER, MD -1.29 kg) which is direction-consistent with He 2026 (IF reduced BMI), making the 'positive vs negative' framing of those tensions internally inconsistent with the bundle — the manuscript should reconcile the direction coding before publishing this tension list.

Minor issues

• The Methods section lists '0 records excluded at full-text review' — a 100% inclusion rate is unusual and should be explicitly justified (e.g. pre-filtered upstream) to maintain audit credibility.
• The Background section asserts 'no narrative weight is given to literature the pipeline could not verify end to end' but does not disclose the verification protocol or whether excluded sources exist; a brief note on the funnel would strengthen auditability.
• The Conclusion section repeats the 706 cross-source tension count from the Tensions section verbatim — acceptable, but the figure would benefit from a one-sentence definition of what counts as a non-orthogonal dyad so the reader can audit the magnitude.
• The Research Question text uses the awkward double-plural 'cardiometabolic and contextual adjacent evidence support' — should be rephrased for grammatical clarity.
• The Evidence Snapshot's Source Classification Map truncates the list at 41 of 66 sources; the omitted 25 should either be summarised or an explicit note added that the map highlights the top-claim-count sources only.

Reviewer note

This is a competent, deeply structured research-synthesis manuscript that maps 66 retained sources on intermittent fasting across six outcome classes with explicit evidence-tier and directness coding, an outcome-class map, a pairwise disagreement audit, and a numeric supplement. The presence of recommended depth sections (Cross-Domain Synthesis, Tensions and Gaps, Boundary-Condition Matrix, Evidence-Gap Priority, Next-Study Design Recommendation) signals a serious artifact rather than a loose review. Hedging is appropriate throughout and the conclusion is bounded by the directness profile (11 direct / 55 indirect-or-adjacent). However, several issues prevent acceptance at this pass. The Directness Map under 'What This Synthesis Adds' contradicts the Results outcome-class table for the immune/inflammation and safety slices (claims 0 direct there vs the Results slice showing 0 direct but 2 indirect — the prose Discussion claim of '0 direct' for immune is consistent, but the table's column entries are not internally reconciled across sections). The Tensions and Gaps subsection frames Herz 2024 vs He 2026 and Herz 2024 vs Li 2026 as 'positive vs negative' BMI conflicts, yet the bundle excerpts for He 2026 and Li 2026 both report IF reductions (negative-direction coding), so the surfaced tension misrepresents direction coding from the source set. Several quoted exact numerics (e.g. Couto-Alfonso -1.92 kg, Guo 6.3 kg 95% CI) appear in the prose without matching bundle excerpts and should either be sourced or removed. The Khalafi 2025a inflammatory-marker SMDs (-0.31, -0.19, -0.57 with P values) are in the bundle but are not transcribed into the Immune and Inflammation Results subsection, leaving that slice under-numericed despite source-traceable data being available. The Limitations section is substantive (mortality gap, single-trial endpoints, narrow population, endpoint coverage, mechanism-clinic gap), which is appropriate for a 20k-word claim space. Gaps are specific and actionable (P1–P5 hierarchy with a concrete next-study design recommendation). Source grounding is strong: citations match the bundle for nearly all 66 entries, years and DOIs are consistent, and the deterministic source-tracing architecture (bundle tokens, exact source tokens, DOI/PMID pairs) makes the manuscript auditable at scale. The recommendation is revise: the manuscript is mostly correct and salvageable with bounded edits that (a) reconcile the cross-section direction/ directness inconsistencies, (b) transcribe or remove the unsupported exact numerics, and (c) clarify the surfaced-tension list to match the bundle-coded directions. None of these requires a scope reset or restructuring — they are targeted fixes that can be made in a single revision pass without invalidating the underlying synthesis architecture.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v12-grounded-integrity